Tulobuterol
Chemical compound
- R03AC11 (WHO)
- AU: S4 (Prescription only)
- In general: ℞ (Prescription only)
- (RS)-2-(tert-butylamino)-1-(2-chlorophenyl)ethanol
- 41570-61-0
N
- 5606
- 5404
Y
- 591I9SU0F7
- D02151
Y
- ChEMBL1159717
Y
- DTXSID7048457
![Edit this at Wikidata](http://upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png)
- Interactive image
- Clc1ccccc1C(O)CNC(C)(C)C
InChI
- InChI=1S/C12H18ClNO/c1-12(2,3)14-8-11(15)9-6-4-5-7-10(9)13/h4-7,11,14-15H,8H2,1-3H3
Y
- Key:YREYLAVBNPACJM-UHFFFAOYSA-N
Y
![☒](http://upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png)
![check](http://upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png)
![](http://upload.wikimedia.org/wikipedia/commons/thumb/5/5c/Hokunalin_tape.png/220px-Hokunalin_tape.png)
Tulobuterol (INN) is a long-acting beta2-adrenergic receptor agonist, marketed in Japan as a transdermal patch under the name Hokunalin tape (ホクナリンテープ).[1]
Currently, it is only legal in 7 countries: Japan, Germany, China, South Korea, Bangladesh, Pakistan, and Venezuela. It is available in India also.
References
- ^ Horiguchi T, Kondo R, Miyazaki J, Fukumokto K, Torigoe H (2011). "Clinical evaluation of a transdermal therapeutic system of the beta2-agonist tulobuterol in patients with mild or moderate persistent bronchial asthma". Arzneimittel-Forschung. 54 (5): 280–5. doi:10.1055/s-0031-1296971. PMID 15212190. S2CID 9765046.
- v
- t
- e
Adrenergic receptor modulators
- See also: Receptor/signaling modulators
- Dopaminergics
- Serotonergics
- Monoamine reuptake inhibitors
- Monoamine releasing agents
- Monoamine metabolism modulators
- Monoamine neurotoxins
![]() | This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e